Back to Studies

IMPAACT 2035

A Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of VPM1002 and BCG Re-Vaccination in Pre-Adolescents

Study Status

In Development

Locality

Non-US
Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...